For tax years beginning in 2027 or later, Minnesota taxpayers would add federal deductions for consumer prescription medicine marketing back to income when calculating state taxes.
Minnesota taxpayers would add federal deductions for marketing prescription medicines to U.S. consumers back to taxable income. This would apply to individual income and corporate franchise taxes for tax years beginning in 2027 or later.
Taxpayers would add covered federal marketing deductions back to income when calculating Minnesota taxes. The rule would cover expenses deducted under federal business-expense rules for Minnesota individual income and corporate franchise taxes. The marketing must target U.S. consumers and aim to promote the use, purchase, or prescription of prescription drugs or biologic treatments. Covered marketing includes advertising, patient outreach, and disease awareness campaigns. The outreach and campaigns must be funded by a drug manufacturer and linked to a specific product. Both provisions would apply to tax years beginning after December 31, 2026.
No hearings or votes scheduled.